|
The intrinsic potency and duration of action of local anesthetics are clearly dependent on certain features of the molecule.
The lipophilic versus hydrophilic character of local anesthetics depends on the size of the alkyl substituents both on or near the tertiary amine and on the aromatic ring. "Lipophilicity" expresses the tendency of a compound to associate with membrane lipids, which is usually approximated by equilibrium partitioning into a hydrophobic solvent such as octanol.[1] Such octanol/buffer partition coefficients are comparable to membrane/buffer partition coefficients for the uncharged species of local anesthetics but greatly underestimate membrane partitioning for the charged, protonated species, octanol being a poor model for the polar regions near the membrane surface.[2] In this chapter we use the term hydrophobicity, expressed by octanol/buffer partitioning, to describe a physicochemical property of local anesthetics.
Compounds with a more hydrophobic nature are obtained by increasing the size of the alkyl substituent or substituents. These agents are more potent and produce longer-lasting blocks than their less hydrophobic congeners do.[3] [4] [5] For example, etidocaine, which has three more carbon atoms than lidocaine has in the amine end of the molecule, is four times as potent and five times as long lasting when compared for impulse blockade in the isolated sciatic nerve.
Local anesthetics in solution exist in a rapid chemical equilibrium
between the basic uncharged form (B) and the charged cationic form (BH+
).
At a certain hydrogen ion concentration (log10
-1
[-pH]) specific
for each drug, the concentration of local anesthetic base in solution is equal to
the concentration of charged cation. This hydrogen ion concentration is called pKa
.
The relationship is defined by
pKa values for standard local anesthetics are listed in Table 14-2 . The tendency to be protonated also depends on environmental factors, such as temperature and ionic strength, and on the medium surrounding the drug. In the relatively apolar milieu of a membrane, the average pKa of local anesthetics is lower than in solution.[6] This is chemically equivalent to saying that the membrane concentrates the base form of the local anesthetic more than it concentrates the protonated cation form.
The pH of the medium containing the local anesthetic influences drug activity by altering the relative percentage of the basic or protonated forms. For example, in inflamed tissue, the pH is lower than normal, and local anesthetics are more protonated than in normal tissue and thus penetrate the tissue relatively poorly (see later).
The relationship between pKa and the percentage of local anesthetic present in the cationic form is shown in
Generic * and Common Proprietary Name | Chemical Structure | Approximate Year of Initial Clinical Use | Main Anesthetic Use | Representative Commercial Preparation |
---|---|---|---|---|
Cocaine | 1884 | Topical | Bulk powder | |
Benzocaine (Americaine) | 1900 | Topical | 20% ointment | |
|
|
|
Topical | 20% aerosol |
Procaine (Novocain) | 1905 | Infiltration | 10- and 20-mg/mL solutions | |
|
|
|
Spinal | 100-mg/mL solution |
Dibucaine (Nupercaine) | 1929 | Spinal | 0.667-, 2.5-, and 5-mg/mL solutions | |
Tetracaine (Pontocaine) | 1930 | Spinal | Niphanoid crystals—20- and 10-mg/mL solutions | |
Lidocaine (Xylocaine) | 1944 | Infiltration | 5- and 10-mg/mL solutions | |
|
|
|
Peripheral nerve blockade | 10-, 15-, and 20-mg/mL solutions |
|
|
|
Epidural | 10-, 15-, and 20-mg/mL solutions |
|
|
|
Spinal | 50-mg/mL solution |
|
|
|
Topical | 2.0% jelly, viscous |
|
|
|
Topical | 2.5%, 5.0% ointment |
Chloroprocaine (Nesacaine) | 1955 | Infiltration | 10-mg/mL solution | |
|
|
|
Peripheral nerve blockade | 10- and 20-mg/mL solutions |
|
|
|
Epidural | 20- and 30-mg/mL solutions |
Mepivacaine (Carbocaine) | 1957 | Infiltration | 10-mg/mL solution | |
|
|
|
Peripheral nerve blockade | 10- and 20-mg/mL solutions |
|
|
|
Epidural | 10-, 15-, and 20-mg/mL solutions |
Prilocaine (Citanest) | 1960 | Infiltration | 10- and 20-mg/mL solutions | |
|
|
|
Peripheral nerve blockade | 10-, 20-, and 30-mg/mL solutions |
|
|
|
Epidural | 10-, 20-, and 30-mg/mL solutions |
Bupivacaine (Marcaine) | 1963 | Infiltration | 2.5-mg/mL solution | |
|
|
|
Peripheral nerve blockade | 2.5- and 5-mg/mL solutions |
|
|
|
Epidural | 2.5-, 5-, and 7.5-mg/mL solutions |
|
|
|
Spinal | 5- and 7.5-mg/mL solutions |
Ropivacaine (Naropin) | 1992 | Infiltration | 2.5- and 5-mg/mL solutions | |
|
|
|
Peripheral nerve blockade | 5- and 10-mg/mL solutions |
|
|
|
Epidural | 5- and 7.5-mg/mL solutions |
Modified from Covino B, Vassallo H: Local Anesthetics: Mechanisms of Action and Clinical Use. Orlando, FL, Grune & Stratton, 1976. |
|
|
Physicochemical Properties | |
---|---|---|---|
Drug | Relative Conduction-Blocking Potency * | pKa † | Hydrophobicity † |
Low-potency procaine | 1 | 8.9 | 100 |
Intermediate potency |
|
|
|
Mepivacaine | 1.5 | 7.7 | 130 |
Prilocaine | 1.8 | 8.0 ‡ | 129 |
Chloroprocaine | 3 | 9.1 | 810 |
Lidocaine | 2 | 7.8 | 366 |
High potency |
|
|
|
Tetracaine | 8 | 8.4 | 5822 |
Bupivacaine | 8 | 8.1 | 3420 |
Etidocaine | 8 | 7.9 | 7320 |
From Strichartz GR, Sanchez V, Arthur GR, et al: Fundamental properties of local anesthetics. II. Measured octanol:buffer partition coefficients and pKa values of clinically used drugs. Anesth Analg 71:158–170, 1990. |
|